Nancy Chang

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-08-18

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$66M

across 1 round

LATEST ROUND

Series D · $66M · 2026-08-18

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Abcuro Breakthrough therapies for autoimmune diseases and cancer for patients with specific conditions.	Series D Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$66M	2026-08-18	[ PART ]